|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI
|
|
2
|
Nagtegaal ID, Odze RD, Klimstra D, Paradis
V, Rugge M, Schirmacher P, Washington KM, Carneiro F and Cree IA;
WHO Classification of Tumours Editorial Board, : The 2019 WHO
classification of tumours of the digestive system. Histopathology.
76:182–188. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jiang C, Liu Y, Xu C, Shen Y, Xu Q and Gu
L: Pathological features of lymph nodes around inferior mesenteric
artery in rectal cancer: A retrospective study. World J Surg Oncol.
19:1522021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Junginger T, Goenner U, Hitzler M, Trinh
TT, Heintz A, Wollschlaeger D and Blettner M: Long-term oncologic
outcome after transanal endoscopic microsurgery for rectal
carcinoma. Dis Colon Rectum. 59:8–15. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Garcia-Aguilar J, Renfro LA, Chow OS, Shi
Q, Carrero XW, Lynn PB, Thomas CR Jr, Chan E, Cataldo PA, Marcet
JE, et al: Organ preservation for clinical T2N0 distal rectal
cancer using neoadjuvant chemoradiotherapy and local excision
(ACOSOG Z6041): Results of an open-label, single-arm,
multi-institutional, phase 2 trial. Lancet Oncol. 16:1537–1546.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Glynne-Jones R, Wyrwicz L, Tiret E, Brown
G, Rödel C, Cervantes A and Arnold D; ESMO Guidelines Committee, :
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis,
treatment and follow-up. Ann Oncol. 29 (Suppl 4):iv2632018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ueno H, Hase K, Hashiguchi Y, Shimazaki H,
Yoshii S, Kudo SE, Tanaka M, Akagi Y, Suto T, Nagata S, et al:
Novel risk factors for lymph node metastasis in early invasive
colorectal cancer: A multi-institution pathology review. J
Gastroenterol. 49:1314–1323. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Doornebosch PG, Ferenschild FT, de Wilt
JH, Dawson I, Tetteroo GW and de Graaf EJ: Treatment of recurrence
after transanal endoscopic microsurgery (TEM) for T1 rectal cancer.
Dis Colon Rectum. 53:1234–1239. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hahnloser D, Wolff BG, Larson DW, Ping J
and Nivatvongs S: Immediate radical resection after local excision
of rectal cancer: An oncologic compromise? Dis Colon Rectum.
48:429–437. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fields AC, Lu P, Hu F, Hirji S, Irani J,
Bleday R, Melnitchouk N and Goldberg JE: Lymph node positivity in
T1/T2 rectal cancer: A word of caution in an era of increased
incidence and changing biology for rectal cancer. J Gastrointest
Surg. 25:1029–1035. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Horvat N, Carlos Tavares Rocha C, Clemente
Oliveira B, Petkovska I and Gollub MJ: MRI of rectal cancer: Tumor
staging, imaging techniques, and management. Radiographics.
39:367–387. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kleiner DE: Hepatocellular carcinoma:
Liver biopsy in the balance. Hepatology. 68:13–15. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Song M, Li S, Wang H, Hu K, Wang F, Teng
H, Wang Z, Liu J, Jia AY, Cai Y, et al: MRI radiomics independent
of clinical baseline characteristics and neoadjuvant treatment
modalities predicts response to neoadjuvant therapy in rectal
cancer. Br J Cancer. 127:249–257. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ameli S, Venkatesh BA, Shaghaghi M,
Ghadimi M, Hazhirkarzar B, Rezvani Habibabadi R, Aliyari Ghasabeh
M, Khoshpouri P, Pandey A, Pandey P, et al: Role of MRI-derived
radiomics features in determining degree of tumor differentiation
of hepatocellular carcinoma. Diagnostics (Basel). 12:23862022.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu HF, Lu Y, Wang Q, Lu YJ and Xing W:
Machine learning-based CEMRI radiomics integrating LI-RADS features
achieves optimal evaluation of hepatocellular carcinoma
differentiation. J Hepatocell Carcinoma. 10:2103–2115. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hirata E and Sahai E: Tumor
microenvironment and differential responses to therapy. Cold Spring
Harb Perspect Med. 7:a0267812017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu HF, Wang M, Wang Q, Lu Y, Lu YJ, Sheng
Y, Xing F, Zhang JL, Yu SN and Xing W: Multiparametric MRI-based
intratumoral and peritumoral radiomics for predicting the
pathological differentiation of hepatocellular carcinoma. Insights
Imaging. 15:972024. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Park H, Kim KA, Jung JH, Rhie J and Choi
SY: MRI features and texture analysis for the early prediction of
therapeutic response to neoadjuvant chemoradiotherapy and tumor
recurrence of locally advanced rectal cancer. Eur Radiol.
30:4201–4211. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim JH, Shin JK, Lee H, Lee DH, Kang JH,
Cho KH, Lee YG, Chon K, Baek SS and Park Y: Improving the
performance of machine learning models for early warning of harmful
algal blooms using an adaptive synthetic sampling method. Water
Res. 207:1178212021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Khan TM, Xu S, Khan ZG and Uzair Chishti
M: Implementing multilabeling, ADASYN, and relieff techniques for
classification of breast cancer diagnostic through machine
learning: Efficient computer-aided diagnostic system. J Healthc
Eng. 2021:55776362021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bates DDB, Homsi ME, Chang KJ, Lalwani N,
Horvat N and Sheedy SP: MRI for rectal cancer: Staging, mrCRM,
EMVI, lymph node staging and post-treatment response. Clin
Colorectal Cancer. 21:10–18. 2022.PubMed/NCBI
|
|
22
|
Xu F, Hong J and Wu X: An integrative
clinical and intra- and peritumoral MRI radiomics nomogram for the
preoperative prediction of lymphovascular invasion in rectal
cancer. Acad Radiol. 32:3989–4001. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nayak P, Sinha S, Goda JS, Sahu A, Joshi
K, Choudhary OR, Mhatre R, Mummudi N and Agarwal JP: Computerized
tomography-based first order tumor texture features in non-small
cell lung carcinoma treated with concurrent chemoradiation: A
simplistic and potential surrogate imaging marker for survival. J
Cancer Res Ther. 19:366–375. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bernatowicz K, Amat R, Prior O, Frigola J,
Ligero M, Grussu F, Zatse C, Serna G, Nuciforo P, Toledo R, et al:
Radiomics signature for dynamic monitoring of tumor inflamed
microenvironment and immunotherapy response prediction. J
Immunother Cancer. 13:e0091402025. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang X, Dai S, Wang Q, Chai X and Xian J:
Investigation of MRI-based radiomics model in differentiation
between sinonasal primary lymphomas and squamous cell carcinomas.
Jpn J Radiol. 39:755–762. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hanahan D: Hallmarks of cancer: New
dimensions. Cancer Discov. 12:31–46. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang L, Yang Y, Wang T, Chen X, Tang M,
Deng J, Cai Z and Cui W: Intratumoral and peritumoral MRI-based
radiomics prediction of histopathological grade in soft tissue
sarcomas: A two-center study. Cancer Imaging. 23:1032023.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lin P, Xie W, Li Y, Zhang C, Wu H, Wan H,
Gao M, Liang F, Han P, Chen R, et al: Intratumoral and peritumoral
radiomics of MRIs predicts pathologic complete response to
neoadjuvant chemoimmunotherapy in patients with head and neck
squamous cell carcinoma. J Immunother Cancer. 12:e0096162024.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jiang Y, Wang H, Wu J, Chen C, Yuan Q,
Huang W, Li T, Xi S, Hu Y, Zhou Z, et al: Noninvasive imaging
evaluation of tumor immune microenvironment to predict outcomes in
gastric cancer. Ann Oncol. 31:760–768. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pérez-Morales J, Tunali I, Stringfield O,
Eschrich SA, Balagurunathan Y, Gillies RJ and Schabath MB:
Peritumoral and intratumoral radiomic features predict survival
outcomes among patients diagnosed in lung cancer screening. Sci
Rep. 10:105282020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li Y, Wang P, Xu J, Shi X, Yin T and Teng
F: Noninvasive radiomic biomarkers for predicting pseudoprogression
and hyperprogression in patients with non-small cell lung cancer
treated with immune checkpoint inhibition. Oncoimmunology.
13:23126282024. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang X, Wei M, Chen Y, Jia J, Zhang Y, Dai
Y, Qin C, Bai G and Chen S: Intratumoral and peritumoral MRI-based
radiomics for predicting extrapelvic peritoneal metastasis in
epithelial ovarian cancer. Insights Imaging. 15:2812024. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Barge P, Oevermann A, Maiolini A and
Durand A: Machine learning predicts histologic type and grade of
canine gliomas based on MRI texture analysis. Vet Radiol
Ultrasound. 64:724–732. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Scaife CL and Curley SA: Complication,
local recurrence, and survival rates after radiofrequency ablation
for hepatic malignancies. Surg Oncol Clin N Am. 12:243–255. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Margonis GA, Sergentanis TN,
Ntanasis-Stathopoulos I, Andreatos N, Tzanninis IG, Sasaki K,
Psaltopoulou T, Wang J, Buettner S, Papalois ΑE, et al: Impact of
surgical margin width on recurrence and overall survival following
R0 hepatic resection of colorectal metastases: A systematic review
and meta-analysis. Ann Surg. 267:1047–1055. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tang X, Huang H, Du P, Wang L, Yin H and
Xu X: Intratumoral and peritumoral CT-based radiomics strategy
reveals distinct subtypes of non-small-cell lung cancer. J Cancer
Res Clin Oncol. 148:2247–2260. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cheng J, Liu J, Yue H, Bai H, Pan Y and
Wang J: Prediction of glioma grade using intratumoral and
peritumoral radiomic features from multiparametric MRI images.
IEEE/ACM Trans Comput Biol Bioinform. 19:1084–1095. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim HR, Kim SH and Nam KH: Association
between dynamic contrast-enhanced MRI parameters and prognostic
factors in patients with primary rectal cancer. Curr Oncol.
30:2543–2554. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shen FU, Lu J, Chen L, Wang Z and Chen Y:
Diagnostic value of dynamic contrast-enhanced magnetic resonance
imaging in rectal cancer and its correlation with tumor
differentiation. Mol Clin Oncol. 4:500–506. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Curvo-Semedo L, Lambregts DM, Maas M,
Beets GL, Caseiro-Alves F and Beets-Tan RG: Diffusion-weighted MRI
in rectal cancer: Apparent diffusion coefficient as a potential
noninvasive marker of tumor aggressiveness. J Magn Reson Imaging.
35:1365–1371. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhou B, Zhou Y, Tang Y, Bao Y, Zou L, Yao
Z and Feng X: Intravoxel incoherent motion MRI for rectal cancer:
Correlation of diffusion and perfusion characteristics with
clinical-pathologic factors. Acta Radiol. 64:898–906. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Barresi V, Reggiani Bonetti L, Branca G,
Di Gregorio C, Ponz de Leon M and Tuccari G: Colorectal carcinoma
grading by quantifying poorly differentiated cell clusters is more
reproducible and provides more robust prognostic information than
conventional grading. Virchows Arch. 461:621–628. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yuan Y, Chen XL, Li ZL, Chen GW, Liu H,
Liu YS, Pang MH, Liu SY, Pu H and Li H: The application of apparent
diffusion coefficients derived from intratumoral and peritumoral
zones for assessing pathologic prognostic factors in rectal cancer.
Eur Radiol. 32:5106–5118. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lou S, Huang Y, Du F, Xue J, Mo G, Li H,
Yu Z, Li Y, Wang H, Huang Y, et al: Development and validation of a
deep learning-based pathomics signature for prognosis and
chemotherapy benefits in colorectal cancer: A retrospective
multicenter cohort study. Front Immunol. 16:16029092025. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Huang YQ, Chen XB, Cui YF, Yang F, Huang
SX, Li ZH, Ying YJ, Li SY, Li MH, Gao P, et al: Enhanced risk
stratification for stage II colorectal cancer using deep
learning-based CT classifier and pathological markers to optimize
adjuvant therapy decision. Ann Oncol. 36:1178–1189. 2025.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Oh SY, Park JY, Yang KM, Jeong SA, Kwon
YJ, Jung YT, Ma CH, Yun KW, Yoon KH, Kwak JY and Yu CS: Oncologic
outcomes of surgically treated colorectal cancer in octogenarians:
A comparative study using inverse probability of treatment
weighting (IPTW). BMC Gastroenterol. 25:2762025. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yang Y, Xu H, Chen G and Pan Y: Stratified
prognostic value of pathological response to preoperative treatment
in yp II/III rectal cancer. Front Oncol. 11:7951372021. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tjandra JJ, Kilkenny JW, Buie WD, Hyman N,
Simmang C, Anthony T, Orsay C, Church J, Otchy D, Cohen J, et al:
Practice parameters for the management of rectal cancer (revised).
Dis Colon Rectum. 48:411–423. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Cho SH, Park BS, Son GM, Kim HS, Kim SJ,
Park SB, Choi CW, Kim HW, Shin DH and Yun MS: Differences in
factors predicting lymph node metastasis between pT1 rectal cancer
and pT1 colon cancer: A retrospective study. Am Surg. 89:5829–5836.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Emile SH, Horesh N, Garoufalia Z, Gefen R,
Wignakumar A and Wexner SD: Development and validation of a
predictive score for preoperative detection of lymphovascular
invasion in rectal cancer. J Surg Oncol. 131:1081–1089. 2025.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Keller DS, Berho M, Perez RO, Wexner SD
and Chand M: The multidisciplinary management of rectal cancer. Nat
Rev Gastroenterol Hepatol. 17:414–429. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Shibutani M, Maeda K, Nagahara H, Ohtani
H, Sakurai K, Toyokawa T, Kubo N, Tanaka H, Muguruma K, Ohira M and
Hirakawa K: Significance of CEA and CA19-9 combination as a
prognostic indicator and for recurrence monitoring in patients with
stage II colorectal cancer. Anticancer Res. 34:3753–3758.
2014.PubMed/NCBI
|
|
53
|
Ryuk JP, Choi GS, Park JS, Kim HJ, Park
SY, Yoon GS, Jun SH and Kwon YC: Predictive factors and the
prognosis of recurrence of colorectal cancer within 2 years after
curative resection. Ann Surg Treat Res. 86:143–151. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Wang J, Wang X, Yu F, Chen J, Zhao S,
Zhang D, Yu Y, Liu X, Tang H and Peng Z: Combined detection of
preoperative serum CEA, CA19-9 and CA242 improve prognostic
prediction of surgically treated colorectal cancer patients. Int J
Clin Exp Pathol. 8:14853–14863. 2015.PubMed/NCBI
|
|
55
|
Farag CM, Antar R, Akosman S, Ng M and
Whalen MJ: What is hemoglobin, albumin, lymphocyte, platelet (HALP)
score? A comprehensive literature review of HALP's prognostic
ability in different cancer types. Oncotarget. 14:153–172. 2023.
View Article : Google Scholar : PubMed/NCBI
|
